Kiniksa Pharmaceuticals International PLC (NAS:KNSA)
$ 22.32 0.28 (1.27%) Market Cap: 1.61 Bil Enterprise Value: 1.40 Bil PE Ratio: 0 PB Ratio: 3.69 GF Score: 58/100

Kiniksa Pharmaceuticals Ltd Annual Shareholders Meeting Transcript

Jun 30, 2020 / 12:00PM GMT
Release Date Price: $25.48 (-2.00%)
Thomas W. Beetham
Kiniksa Pharmaceuticals, Ltd. - Executive VP of Corporate Development & Operations, Chief Legal Officer and Secretary

At the top of the hour, it's 8 a.m. Eastern Time, 9 a.m. Atlantic time, we're going to get started. Welcome to the 2020 Annual Meeting of Kiniksa Pharmaceuticals Limited. My name is Tom Beetham. I'm the Chief Legal Officer and Secretary of the company.

A quorum is present, and I declare this meeting to be open. Before I turn the meeting over to the Chairman of the Board, there are a few procedural matters that I'd like to review. The notice of the meeting was distributed on or about April 28, 2020, to all shareholders of record entitled to vote at this meeting as of the close of business on the record date of April 22.

We refer to these shareholders during this meeting as our record holders. In coordination with Broadridge Financial Solutions, Jenna Bentley of Borden Consulting Group has been appointed to serve as inspector of elections for this meeting. Jenna will be supervising the counting and tabulating of all the votes. If you have already

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot